⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for pleomorphic variant mantle cell lymphoma

Every month we try and update this database with for pleomorphic variant mantle cell lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell LymphomaNCT05861050
Blastoid Varian...
Mantle Cell Lym...
Pleomorphic Var...
Biopsy
Biospecimen Col...
Bone Marrow Bio...
Computed Tomogr...
Glofitamab
Lenalidomide
Obinutuzumab
Positron Emissi...
Venetoclax
18 Years - 80 YearsCity of Hope Medical Center
Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaNCT03946878
Blastoid Varian...
CCND1 Protein O...
CD20 Positive
CD5 Positive
FCER2 Negative
Pleomorphic Var...
Recurrent Mantl...
Refractory Mant...
t(11;14)(q13;q3...
Acalabrutinib
Venetoclax
18 Years - M.D. Anderson Cancer Center
Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell LymphomaNCT02427620
Blastoid Varian...
Mantle Cell Lym...
Pleomorphic Var...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin
Doxorubicin Hyd...
Ibrutinib
Laboratory Biom...
Methotrexate
Rituximab
Vincristine
Vincristine Sul...
18 Years - 65 YearsM.D. Anderson Cancer Center
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell LymphomaNCT05861050
Blastoid Varian...
Mantle Cell Lym...
Pleomorphic Var...
Biopsy
Biospecimen Col...
Bone Marrow Bio...
Computed Tomogr...
Glofitamab
Lenalidomide
Obinutuzumab
Positron Emissi...
Venetoclax
18 Years - 80 YearsCity of Hope Medical Center
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell LymphomaNCT05861050
Blastoid Varian...
Mantle Cell Lym...
Pleomorphic Var...
Biopsy
Biospecimen Col...
Bone Marrow Bio...
Computed Tomogr...
Glofitamab
Lenalidomide
Obinutuzumab
Positron Emissi...
Venetoclax
18 Years - 80 YearsCity of Hope Medical Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: